about
Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetesNovel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11-14 year olds: The HEALTHY Study.A deletion in the long arm of chromosome 18 in a child with serum carnosinase deficiency.The effects of a high-protein, low-fat, ketogenic diet on adolescents with morbid obesity: body composition, blood chemistries, and sleep abnormalities.Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial.Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN).Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.The association between acanthosis nigricans and dysglycemia in an ethnically diverse group of eighth grade studentsAntithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial.The effect of insulin on expression of genes and biochemical pathways in human skeletal muscle.Implementation of a clinical practice guideline for identification of microalbuminuria in the pediatric patient with type 1 diabetes.Endocrine Effects of Inhaled Corticosteroids in Children.Response to Comment on Weber et al. Type 1 Diabetes is Associated With an Increased Risk of Fracture Across the Life Span: A Population-Based Cohort Study Using The Health Improvement Network (THIN). Diabetes Care 2015;38:1913-1920.Effects of genetic severity on glucose homeostasis in Friedreich ataxiaTroglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.Effect of Financial Incentives on Glucose Monitoring Adherence and Glycemic Control Among Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.How low can we go...safely?: factors affecting intensive diabetes management.Cross-sectional analysis of glucose metabolism in Friedreich ataxia.Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control.Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study.Evaluation of ADA HbA1c criteria in the diagnosis of pre-diabetes and diabetes in a population of Chinese adolescents and young adults at high risk for diabetes: a cross-sectional studyA0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trialEndogenous mutations in human uncoupling protein 3 alter its functional propertiesIncreased serum 1,25-dihydroxyvitamin D after growth hormone administration is not parathyroid hormone-mediatedElevation of serum cardiac troponin I in a cross-sectional cohort of asymptomatic subjects with Friedreich ataxiaEffectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 studyInsulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS studyCirculating Osteonectin and Adipokine Profiles in Relation to Metabolically Healthy Obesity in Chinese Children: Findings From BCAMSEligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic RegistryVitamin D levels are associated with metabolic syndrome in adolescents and young adults: The BCAMS studyPoor Glycemic Control Is Associated With Impaired Bone Accrual in the Year Following a Diagnosis of Type 1 DiabetesBiologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic networkAdipose Tissue Mediates Associations of Birth Weight with Glucose Metabolism Disorders in ChildrenA structured 1-year education program for children with newly diagnosed type 1 diabetes improves early glycemic control
P50
Q24564520-317396B2-7910-48DB-B417-69ED54188219Q30781511-23055735-8ED5-486D-BA18-CB2A4ABEB893Q34416151-8C6286B1-D0AE-40D4-9198-F05B1336CBBEQ34744123-121BC32A-50EC-494A-8911-C2AF5AFF7E32Q35096754-7A9B9D12-9D99-4B74-A4CE-427CC686CBA2Q36087289-31355AAB-F2C6-4B98-A3E5-283148D1B56FQ36216535-B94883A8-D90B-44E8-BA2C-4F5BA9D7594FQ36778812-F419F72A-5D6D-4CAD-A651-C4B2696F35CBQ36908165-36A9481D-C9A6-40AD-96A7-0D3FC6BF3B57Q38299058-FD1EF76F-4938-46C9-840D-62FC1FF032B6Q38408325-B91DA5ED-9D94-473B-92DE-A79AADF79FD9Q38683918-F973DB47-22CE-4AA1-8F02-E516CD47C563Q42320389-F7E2EC46-BB61-4376-805A-13F3006BF94DQ42859119-970C8107-DE4A-4C7F-9B03-E37255D6CADAQ44155459-5A2C21C5-34D2-472E-BB7A-352E4E495BD5Q47312338-530E7050-6B77-41F3-894A-C62B5DA495E6Q51151721-4D01E5C5-88B3-47E7-B19F-D06165065AD8Q51322738-A0FC722C-638F-4006-9213-FC5EC40629B7Q53077754-31248392-D46C-43A8-A830-DAB73848BE44Q53682631-4DB784D9-4366-4D07-9127-33DB1A87EDACQ58795583-4CB8F626-4B5F-4D46-8D63-25986D665EF1Q60726008-9DA34B29-EE39-411A-84FD-57DC26742573Q73318457-15535A35-795D-4041-B60E-34188D3B2828Q73736416-7C6ECD77-E8E4-4A16-84B0-0B896C98F0C1Q84224132-7DEB4772-7032-4808-898C-FA5B2ACEC346Q84488091-E1802B02-263F-410C-B3BE-37EB6C9A1634Q89677277-9250C459-BA39-417A-A15F-42DC3452E189Q90669233-8EBB5D92-DEAB-4D13-8677-252B314F3172Q91268964-C97C0739-623C-44B6-BD70-F905E854D879Q91590000-F454C110-70B9-4D10-9E76-B52C5AB99ECDQ91599978-158077AD-3F14-406A-B797-B165C68075E6Q91676501-B076C71F-3B30-488B-8CE7-54669CAC1B27Q91961913-44A52237-697A-4288-A8FB-0FBC16327877Q92740561-7BB5CB40-1C33-4488-BB63-80AA540078D3
P50
description
Forscher
@de
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究員
@ja
研究者
@zh
name
S M Willi
@en
S M Willi
@nl
type
label
S M Willi
@en
S M Willi
@nl
prefLabel
S M Willi
@en
S M Willi
@nl
P106
P31
P496
0000-0002-4910-2425